HCA Healthcare, Inc. (NYSE:HCA) Shares Purchased by Railway Pension Investments Ltd

Railway Pension Investments Ltd increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 148,367 shares of the company’s stock after acquiring an additional 5,100 shares during the quarter. Railway Pension Investments Ltd’s holdings in HCA Healthcare were worth $49,485,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare in the first quarter worth $231,000. New Mexico Educational Retirement Board boosted its stake in HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares during the period. Apexium Financial LP acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $361,000. Sanders Capital LLC grew its holdings in HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares in the last quarter. Finally, Todd Asset Management LLC raised its stake in HCA Healthcare by 17.2% during the 4th quarter. Todd Asset Management LLC now owns 226,563 shares of the company’s stock valued at $61,326,000 after acquiring an additional 33,271 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 1.9 %

HCA Healthcare stock traded down $6.76 during mid-day trading on Friday, hitting $356.36. The company’s stock had a trading volume of 1,604,536 shares, compared to its average volume of 1,536,892. The company has a market cap of $91.97 billion, a PE ratio of 17.76, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $369.41. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The firm’s 50 day moving average is $334.20 and its 200 day moving average is $324.85.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the prior year, the business earned $4.29 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. On average, analysts anticipate that HCA Healthcare, Inc. will post 22.43 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. HCA Healthcare’s payout ratio is 13.16%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Barclays increased their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. SVB Leerink upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $327.00 to $332.00 and gave the company a “neutral” rating in a research report on Thursday, May 30th. Truist Financial lifted their target price on HCA Healthcare from $375.00 to $390.00 and gave the stock a “buy” rating in a report on Wednesday, July 24th. Finally, Robert W. Baird began coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $344.06.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The disclosure for this sale can be found here. Insiders sold 20,268 shares of company stock worth $6,804,285 over the last ninety days. 1.60% of the stock is currently owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.